Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® LLC is welcoming Robert “Bo” Brannin as its new Senior Director of Operations.
In this position, Brannin will be responsible for managing every aspect of the company’s supply chain operations from purchasing to inventory, production and shipping. He will bring his twenty years of experience in the operations and logistics field to assist the team in building a strong foundation as the company now prepares to establish international operations.
“We are excited to bring Bo onto the executive team as Senior Director of Operations and we are more than confident that he has the experience and skills required to effectively serve all of Kannaway’s loyal customers and Brand Ambassadors.” said Kannaway CEO, Blake Schroeder.
“It is my firm belief that it is critical to not only share my knowledge of lean manufacturing as it pertains to operations but also vital to build a promising environment and culture for our employees so that everyone is involved in the process,” said Brannin. “I am incredibly proud to be a part of this team that has helped so many, and continues to be a leader in this industry.”
About Kannaway, LLC Kannaway, LLC is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
CONTACT:Public Relations Contact:Andrew HardChief Executive OfficerCMW MediaP: 888-829- email@example.com
View original content with multimedia:http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-robert-bo-brannin-as-senior-director-of-operations-for-subsidiary-kannaway-300538513.html
SOURCE Medical Marijuana, Inc.